EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY 4.0

A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis

Rachael J L Tan iD, Anusha Ahuja, Aakanksha Shrestha, Geraldine Gallen, Ben Stotesbury, Yee Cheah, Omar G Mustafa, Martin B Whyte, Jonathan Croos, Adam Shooshtarian, Bu' Hussain Hayee, Marietta Stadler iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70575 ↗

At a glance

Beobachtungsstudie in Diabetes, Obesity and Metabolism, 2026. Written by Rachael J L Tan and 11 co-authors. Institution: Diabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK. Major MEDLINE topics: Diabetes Mellitus, Type 1, Gastroparesis, Insulin Infusion Systems, Insulin. 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIHR Clinical Lectureship, NIHR Clinician Scientist Fellowship.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

A retrospective observational cohort study evaluating real‐world outcomes in adults with type 1 diabetes and gastroparesis using automated hybrid closed loop insulin delivery systems (HCL). Materials and Methods All adults with type 1 diabetes and gastroparesis attending King's College Hospital diabetes service and using continuous glucose monitoring (CGM) from 5 October 2023 to 16 January 2025 were included. Glycaemic data (HbA 1c , CGM metrics), hypoglycaemia awareness (Gold score), diabetes distress (DDS2), and acute complications (DKA, severe hypoglycaemia) were collected from electronic health records and glucose platforms for 12 months pre‐ and post‐HCL initiation.

Results

From 1827 clinic attendees, 36 adults with gastroparesis were identified, with 17 initiating HCL. HCL and non‐HCL groups had comparable baseline characteristics and metrics (HCL: Mean(SD) HbA 1c 70(21)mmol/mol [8.6(1.9)%]; Time in range (TIR) 36.8 (21.9) % vs. non‐HCL: HbA 1c 71 (25) mmol/mol [8.6(2.3)%]; TIR 37.1(19.2)%, p = 0.73). Post‐HCL, HbA 1c median(IQR) fell to 57(52.5–65.0) mmol/mol [7.4(7.0–8.1)%] ( p < 0.001). TIR increased to 55.7(19.9)% ( p < 0.001), with a significant reduction in Time above range Level 2 (TAR2) [>13.9 mmol/L/>250 mg/dL](32.7% to 14.5%, p = 0.014). Gold score improved (2.5 to 1.5, p = 0.019), but DDS2 remained unchanged. No increase in DKA or severe hypoglycaemia occurred.

Conclusions

Within a specialist multidisciplinary team setting, HCL systems significantly reduce HbA 1c without increasing risk of severe hypoglycaemia or DKA in people with type 1 diabetes and gastroparesis.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1GastroparesisInsulin Infusion SystemsInsulinHypoglycemic AgentsHumansRetrospective StudiesFemaleMaleAdultMiddle AgedContinuous Glucose MonitoringHypoglycemiaBlood GlucoseGlycated HemoglobinTreatment Outcome

Author keywords

CGMautomated insulin deliverygastroparesishybrid closed looptype 1 diabetes mellitus

Substances

InsulinHypoglycemic AgentsBlood GlucoseGlycated Hemoglobin

Authors and institutions

  • Diabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Department of Diabetes, King's College Hospital NHS Foundation Trust, London, UK.
  • Department of Gastroenterology King's College Hospital NHS Foundation Trust, London, UK.

ORCID profiles: Rachael J L Tan, Marietta Stadler

Funding

  • NIHR Clinical Lectureship
  • NIHR Clinician Scientist Fellowship

Cite

APA

Tan, R. J. L., Ahuja, A., Shrestha, A., Gallen, G., Stotesbury, B., Cheah, Y., Mustafa, O. G., Whyte, M. B., Croos, J., Shooshtarian, A., Hayee, B. H., & Stadler, M. (2026). A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70575

Vancouver

Tan RJL, Ahuja A, Shrestha A, Gallen G, Stotesbury B, Cheah Y, et al. A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70575

BibTeX
@article{Tan2026,
  author = {Tan, Rachael J L and Ahuja, Anusha and Shrestha, Aakanksha and Gallen, Geraldine and Stotesbury, Ben and Cheah, Yee and Mustafa, Omar G and Whyte, Martin B and Croos, Jonathan and Shooshtarian, Adam and Hayee, Bu' Hussain and Stadler, Marietta},
  title = {A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70575}
}
Start for free →